Leaderboards/chronic kidney disease and diabetes

chronic kidney disease and diabetes

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Katherine R. Tuttle
Providence College
99
2
Johannes F.E. Mann
Friedrich-Alexander-Universität Erlangen-Nürnberg
90
3
Ellen M. Apperloo
University Medical Center Groningen
70
4
Muthiah Vaduganathan
Brigham and Women's Hospital
60
5
Scott D. Solomon
Brigham and Women's Hospital
50
6
Masaomi Nangaku
The University of Tokyo
30
7
Kenneth W. Mahaffey
Stanford Medicine
20
8
Richard E. Pratley
Translational Research Institute for Metabolism and Diabetes
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Vlado Perkovic
University of Copenhagen
99
2
Yogesh Kumar C -
Unknown
90
3
Brendon L. Neuen
Brigham and Women's Hospital
80
4
Richard Pratley
University of Copenhagen
70
5
Jeanine E. Roeters van Lennep
Erasmus MC
60
6
Rajiv Agarwal
Richard L. Roudebush VA Medical Center
50
7
Dandan Xie
Central South University
20
8
PK Judge
Unknown
10

Emerging Leaders Papers

1
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
The Lancet Diabetes & Endocrinology|2024
247 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Josef Coresh
Johns Hopkins University
99
2
Josephine P. Briggs
Tufts University
90
3
Robert D. Toto
Brigham and Women's Hospital
80
4
Hiddo J.L. Heerspink
University Medical Center Groningen
80
5
Helen M. Colhoun
Edinburgh Cancer Research
70
6
Ian H. de Boer
University of Washington
60
7
Philippe Gabríel Steg
Inserm
50
8
Glenn M. Chertow
Palo Alto University
40
9
Bernard Zinman
Lunenfeld-Tanenbaum Research Institute
30
10
Susanne B. Nicholas
University of California, Los Angeles
30

All-Time Leaders Papers

1
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
New England Journal of Medicine|2015
11.9k cit.
2
Dapagliflozin in Patients with Chronic Kidney Disease
New England Journal of Medicine|2020
5.1k cit.
3
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
New England Journal of Medicine|2016
3.6k cit.
4
Impaired Fasting Glucose and Impaired Glucose Tolerance
Diabetes Care|2007
1.4k cit.
5
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
New England Journal of Medicine|2020
1.2k cit.
6
Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States
JAMA|2011
1k cit.
7
Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
Diabetes Care|2022
806 cit.
8
Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population
Circulation Heart Failure|2014
148 cit.
9
Glucose, Insulin, and Incident Hypertension in the Multi-Ethnic Study of Atherosclerosis
American Journal of Epidemiology|2010
79 cit.
10
Serum Parathyroid Hormone and 25‐Hydroxyvitamin D Concentrations and Risk of Incident Heart Failure: The Multi‐Ethnic Study of Atherosclerosis
Journal of the American Heart Association|2014
78 cit.

Reagents for chronic kidney disease and diabetes

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

Cleaved-PARP (Asp214) (E2T4K) Mouse Monoclonal Antibody

Cited in 11 papers
#32563$179
View Evidence →Cell Signaling Technology

COL1A1 (E8F4L) Rabbit Monoclonal Antibody

Cited in 5 papers
#72026$180
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

NFAT1 (D43B1) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

Cited in 10 papers
#14201$465
View Evidence →Agilent/Dako

Wilms Tumor Protein 1

Cited in 9 papers
#M3561
View Evidence →Cell Signaling Technology

beta-Amyloid (D12B2) Rabbit Monoclonal Antibody

Cited in 8 papers
#9888$161
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

PDGF Receptor alpha (D13C6) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

Cited in 14 papers
#8871$465
View Evidence →Cell Signaling Technology

Cyclic GMP Chemiluminescent Assay Kit

Cited in 12 papers
#8020$459
View Evidence →Cell Signaling Technology

Mono-Methyl Arginine [mme-R] MultiMab® Rabbit Monoclonal Antibody mix

Cited in 12 papers
#8015$194
View Evidence →